Chinook Therapeutics, Inc.

STATE STREET CORP

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/14/2023

Shares

2,907,317

Value ($000)

111,699

Weight

0.0%

2020 Q4 - 2023 Q2 (11 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/14/2023	111,699	0.0%	2,907,317	6/30/2023
2023 Q1	5/15/2023	62,228	0.0%	2,688,048	3/31/2023
2022 Q4	5/15/2023	69,665	0.0%	2,658,956	12/31/2022
2022 Q3	11/15/2022	48,476	0.0%	2,465,719	9/30/2022
2022 Q2	8/15/2022	27,161	0.0%	1,552,941	6/30/2022
2022 Q1	5/16/2022	26,127	0.0%	1,597,002	3/31/2022
2021 Q4	2/14/2022	21,001	0.0%	1,287,640	12/31/2021
2021 Q3	11/15/2021	17,841	0.0%	1,398,169	9/30/2021
2021 Q2	8/16/2021	13,274	0.0%	940,106	6/30/2021
2021 Q1	7/9/2021	4,117	0.0%	264,900	3/31/2021
2020 Q4	2/16/2021	4,543	0.0%	286,457	12/31/2020